At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Registry on WATCHMAN Outcomes in Real-Life Utilization
In Brief
An observational study evaluating WATCHMAN Left Atrial Appendage Closure for Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke. Completed, enrolled 1,025 participants across 47 sites in 13 countries.
Detailed Summary
The WATCHMAN LAA Closure Technology is designed to prevent embolization of thrombi that may form in the LAA, thereby preventing the occurrence of ischemic stroke and systemic thromboembolism. The objectives of this observational, prospective, non-randomized multicenter study are (1) to compile real-world clinical outcomes data for WATCHMAN LAA (left atrial appendage) Close Technology in patients who are implanted with the WATCHMAN device in a commercial clinical setting and (2) to collect real-world usage data that may be needed for reimbursement of WATCHMAN technology in certain countries.